Consistent with the genomic results, we found that GluOC promoted the protein expression of OCT4, NANOG, and SOX2, while Y-27632 attenuated this effect, but the addition of GluOC significantly alleviated the effect of the inhibitor and induced the proliferation of cancer cells. The gene discussed is POU5F1; the disease is cancer.